Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease

Immunotherapy for glioblastoma: current state, challenges, and future perspectives

JAM-A functions as a female microglial tumor suppressor in glioblastoma

The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer